Follow the people · Insider
John Volpone
John Volpone files insider transactions with the SEC as a president of X4 Pharmaceuticals (XFOR). We hold 1 disclosed purchase or sale filed since 14 August 2025, 1 of them in the last 90 days.
- Files forXFOR
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure13 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 12 August 2025 — 12 August 2026President · X4 Pharmaceuticals (XFOR)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
5 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 24,576 shares of X4 PharmaceuticalsSEC Form 413 August 2026Common Stock · traded 12 August 2026 · filed 13 August 2026
- was granted 2,329,154 shares of X4 Pharmaceuticals (a derivative holding)SEC Form 431 October 2025Stock Option (right to buy) · traded 29 October 2025 · filed 31 October 2025
- was granted 1,609,873 shares of X4 Pharmaceuticals (a derivative holding)SEC Form 414 August 2025Stock Option (right to buy) · traded 12 August 2025 · filed 14 August 2025
- was granted 529,201 shares of X4 Pharmaceuticals (a derivative holding)SEC Form 414 August 2025Stock Option (right to buy) · traded 14 August 2025 · filed 14 August 2025
- was granted 289,881 shares of X4 PharmaceuticalsSEC Form 414 August 2025Common Stock · traded 14 August 2025 · filed 14 August 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.